查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1781990

自我监测血糖设备市场（按产品类型、按技术、按检测地点、按患者类型、按最终用户、按国家和地区）－2025 年至 2032 年全球产业分析、市场规模、市场份额及预测

Self-monitoring Blood Glucose Devices Market, By Product Type, By Technology, By Testing Site, By Patient Type, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 284 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年自我监测血糖设备市场规模价值 197.5201 亿美元，2025 年至 2032 年的复合年增长率为 11.53%。

自我监测血糖设备市场-市场动态

糖尿病盛行率上升和技术创新推动自我血糖监测设备需求

糖尿病盛行率的上升，加上科技的快速创新，正推动全球自我血糖监测设备的普及。国际糖尿病联盟报告称，全球约有十分之一的成年人患有糖尿病，凸显了对有效自我照护工具的迫切需求。非侵入式感测器和行动应用程式整合等技术进步，使血糖监测更加便捷和准确。美国疾病管制与预防中心 (CDC) 强调，定期监测血糖可以显着减少併发症，并改善糖尿病患者的生活品质。此外，印度和巴西等国的政府健康计画正在透过补贴和宣传活动，扩大这些设备的普及范围，帮助数百万人更有效地管理自身病情，并减轻医疗系统的负担。

自我监测血糖设备市场—关键洞察

根据我们的研究分析师的分析，预测期内（2025-2032 年）全球市场预计年复合成长率约为 11.53%

根据产品类型细分，自我监测血糖仪 (SMBG) 预计将在 2024 年占据最大市场份额

根据技术细分，电化学技术是2024年的领先技术

根据测试站点细分，Fingertip 是 2024 年领先的测试站点

根据患者类型细分，2 型糖尿病是 2024 年的主要患者类型

根据最终用户细分，家庭护理是 2024 年领先的最终用户

按地区划分，北美是 2024 年的主要收入来源

自我监测血糖设备市场-細項分析：

全球自我监测血糖设备市场根据产品类型、技术、测试地点、患者类型、最终用户和地区进行细分。

根据产品类型，市场分为四类：自我血糖仪 (SMBG)、试纸、采血针和连续血糖监测仪。自我血糖仪 (SMBG) 提供便捷的数位读数追踪，而试纸则确保准确性和快速结果。采血针对于采血至关重要，可最大程度地减少不适感。连续血糖监测仪能够即时追踪血糖，为更好的糖尿病管理提供了动力。

根据技术，市场分为两类：电化学和光度法。电化学技术因其精确性、便携性和成本效益而占据主导地位，常用于SMBG设备。光度法技术虽然不太普及，但因其视觉清晰度和易于解读而受到重视，常用于早期型号和特定的临床应用。

自我监测血糖设备市场—地理洞察

自我监测血糖设备市场呈现出受医疗基础设施、糖尿病盛行率和技术应用影响的区域动态。北美凭藉着先进的医疗体系和高糖尿病发病率领先，推动了对血糖监测设备的需求。紧随其后的是欧洲，其特点是医疗政策健全且糖尿病患者数量众多。由于糖尿病盛行率上升、医疗基础设施改善以及糖尿病管理意识不断提高，亚太地区正在经历快速增长。中国、印度和日本等国家处于这一扩张的前沿。在医疗服务可近性改善和健康意识不断提高的支持下，拉丁美洲、中东和非洲正在逐步采用这些技术。总体而言，市场的成长受到区域医疗保健优先事项、经济状况以及应对糖尿病相关健康挑战的紧迫性的影响。

自我监测血糖设备市场-竞争格局：

自我监测血糖 (SMBG) 设备市场的特征是老牌企业和新兴创新企业之间的激烈竞争。雅培、Dexcom、罗氏诊断、LifeScan 和 Ascensia Diabetes Care 等领先公司凭藉其先进的技术和广泛的分销网络占据了市场主导地位。雅培的 FreeStyle Libre 系列凭藉其感测器技术和经济实惠的价格彻底改变了血糖监测领域，而 Dexcom 的 G6 和 G7 系统则以其准确性和用户友好的设计而闻名。罗氏的 Accu-Chek 系列继续成为许多人的信赖之选，注重可靠性以及与数位健康平台的整合。 LifeScan 的 OneTouch 产品设计简洁、准确，可满足广泛的使用者群体。 Ascensia 的 Contour 系列以其可靠性和用户友好的设计而闻名。市场也见证了新玩家的加入，例如 Ultrahuman，该公司推出了其连续血糖监测仪 Ultrahuman M1，目标客户既包括运动员，也包括注重健康的消费者。策略合作、技术进步以及以使用者为中心的设计是推动 SMBG 设备市场竞争和创新的关键因素。

最新动态：

2024年7月，罗氏公司旗下Accu-Chek SmartGuide®连续血糖监测(CGM)设备取得CE标誌。该设备专为1型和2型糖尿病成人患者设计，提供即时血糖读数和AI驱动的预测警报，以改善患者自我管理。

2024 年 5 月，Intuity Medical 和 embecta 宣布商业合作，以扩大对 Intuity 的 POGO Automatic(R) 血糖监测系统的使用范围，旨在增强全美患者的自我监测选项和糖尿病护理。

2023 年 4 月，安斯泰来与日本罗氏糖尿病护理公司合作开发和商业化以罗氏血糖监测设备和 BlueStar 数位健康平台为特色的综合糖尿病自我管理解决方案，旨在改善日本的糖尿病护理。

目录

第一章：自我监测血糖设备市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 自我监测血糖设备市场（按产品类型）
    • 自我监测血糖设备市场（按技术）
    • 自我监测血糖设备市场片段（按测试站点）
    • 自我监测血糖设备市场（按患者类型）
    • 自我监测血糖设备市场（按最终用户）
    • 自我监测血糖设备市场（按国家/地区）
    • 自我监测血糖设备市场（按地区）
  • 竞争洞察

第三章：自我监测血糖设备的主要市场趋势

  • 自我监测血糖设备的市场驱动因素
    • 市场驱动因素的影响分析
  • 自我监测血糖仪市场限制
    • 市场限制的影响分析
  • 自我监测血糖设备的市场机会
  • 自我监测血糖设备市场未来趋势

第四章：自我监测血糖设备产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：自我监测血糖设备市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：自我监测血糖设备市场格局

  • 2024年自我监测血糖设备市场占有率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：自我监测血糖设备市场－依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 自我监测血糖仪（SMBG）
    • 测试条
    • 刺血针
    • 连续血糖监测仪

第八章：自我监测血糖设备市场 - 依技术

  • 概述
    • 按技术细分的市场份额分析
    • 电化学
    • 光度测定

第九章：自我监测血糖设备市场－按测试地点

  • 概述
    • 按测试站点进行细分份额分析
    • 指尖
    • 备用站点测试

第十章：自我监测血糖设备市场－依病患类型

  • 概述
    • 按患者类型进行细分份额分析
    • 1型糖尿病
    • 2型糖尿病
    • 妊娠糖尿病

第 11 章：自我监测血糖设备市场 - 按下最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 医院
    • 门诊手术中心
    • 诊断中心
    • 居家护理
    • 其他

第 12 章：自我监测血糖设备市场 - 按地区

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美自我监测血糖设备主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按技术）
    • 北美市场规模及预测（按测试地点）
    • 北美市场规模及预测（依患者类型）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲自我监测血糖设备主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模及预测（按测试地点）
    • 欧洲市场规模及预测（依患者类型）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区自我监测血糖设备主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依产品类型）
    • 亚太地区市场规模及预测（依技术）
    • 亚太地区市场规模及预测（依测试地点划分）
    • 亚太地区市场规模及预测（依患者类型）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲自我监测血糖设备主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（依产品类型）
    • 拉丁美洲市场规模及预测（按技术）
    • 拉丁美洲市场规模及预测（按测试站点）
    • 拉丁美洲市场规模及预测（按患者类型）
    • LATAM 规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲自我监测血糖设备主要製造商
    • 中东和非洲市场规模及预测（按国家/地区）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按技术）
    • 中东和非洲市场规模及预测（按测试地点划分）
    • 中东和非洲市场规模及预测（按患者类型）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 13 章：主要供应商分析-自我监测血糖设备产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Abbott Laboratories
    • Acon Laboratories, Inc.
    • ARKRAY, Inc.
    • Ascensia Diabetes Care
    • B. Braun Melsungen AG
    • Bayer AG
    • Dexcom, Inc.
    • Eli Lilly and Company
    • GlucoMe
    • i-SENS, Inc.
    • LifeScan, Inc.
    • Medtronic plc
    • Nipro Corporation
    • Nova Biomedical
    • PHC Holdings Corporation
    • Roche Diagnostics
    • Sanofi
    • Terumo Corporation
    • Trividia Health, Inc.
    • Ypsomed Holding AG

第 14 章：360 度分析师视角

第 15 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5438

REPORT HIGHLIGHT

Self-monitoring Blood Glucose Devices Market size was valued at US$ 19,752.01 Million in 2024, expanding at a CAGR of 11.53% from 2025 to 2032.

The Self-monitoring Blood Glucose Devices Market involves portable devices that enable individuals to measure their blood glucose levels independently, playing a crucial role in diabetes management worldwide. Rising diabetes prevalence and increasing awareness about self-care practices are expanding the demand for these devices. According to the World Health Organization, over 422 million people globally are affected by diabetes, emphasizing the importance of regular glucose monitoring. However, challenges such as high costs of advanced devices and limited accessibility in low-income regions can hinder widespread adoption. Opportunities lie in technological advancements like continuous glucose monitoring integration, non-invasive sensors, and smartphone connectivity, which improve user experience and data accuracy. Additionally, growing government initiatives promoting diabetes screening and management are enhancing market penetration, especially in developing countries where early diagnosis and consistent monitoring can significantly improve patient outcomes.

Self-monitoring Blood Glucose Devices Market- Market Dynamics

Rising diabetes prevalence and tech innovations to boost self-monitoring glucose device demand

Rising diabetes prevalence combined with rapid technological innovations is driving greater adoption of self-monitoring blood glucose devices globally. The International Diabetes Federation reports that approximately 1 in 10 adults worldwide lives with diabetes, underscoring the urgent need for effective self-care tools. Advances such as non-invasive sensors and mobile app integration are making glucose monitoring more convenient and accurate. The U.S. Centers for Disease Control and Prevention (CDC) emphasizes that regular blood glucose monitoring can significantly reduce complications and improve quality of life for diabetic patients. Furthermore, government health programs in countries like India and Brazil are increasing access to these devices through subsidies and awareness campaigns, helping millions manage their condition more effectively and reducing the burden on healthcare systems.

Self-monitoring Blood Glucose Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.53% over the forecast period (2025-2032)

Based on product type segmentation, Self-Monitoring Blood Glucose (SMBG) Meters were predicted to show maximum market share in the year 2024

Based on Technology segmentation, Electrochemical technology was the leading Technology in 2024

Based on Testing Site segmentation, Fingertip was the leading Testing Site in 2024

Based on Patient Type segmentation, Type 2 Diabetes was the leading Patient Type in 2024

Based on end user segmentation, Home Care was the leading end user in 2024

On the basis of region, North America was the leading revenue generator in 2024

Self-monitoring Blood Glucose Devices Market- Segmentation Analysis:

The Global Self-monitoring Blood Glucose Devices Market is segmented on the basis of Product Type, Technology, Testing Site, Patient Type, End User, and Region.

The market is divided into four categories based on product type: Self-Monitoring Blood Glucose (SMBG) Meters, Test Strips, Lancets, and Continuous Glucose Monitors. Self-Monitoring Blood Glucose (SMBG) Meters offer convenient tracking with digital readings, while Test Strips ensure accuracy and quick results. Lancets are vital for blood sampling, offering minimal discomfort. Continuous Glucose Monitors enable real-time glucose tracking, gaining traction for better diabetes management.

The market is divided into two categories based on Technology: Electrochemical and Photometric. Electrochemical technology dominates due to its precision, portability, and cost-effectiveness, commonly used in SMBG devices. Photometric technology, though less prevalent, is valued for its visual clarity and ease of interpretation, often utilized in earlier models and specific clinical applications.

Self-monitoring Blood Glucose Devices Market- Geographical Insights

The Self-Monitoring Blood Glucose Devices Market exhibits regional dynamics influenced by healthcare infrastructure, diabetes prevalence, and technological adoption. North America leads with advanced healthcare systems and high diabetes rates, driving demand for glucose monitoring devices. Europe follows, characterized by robust healthcare policies and a significant diabetic population. The Asia-Pacific region is experiencing rapid growth due to increasing diabetes prevalence, improving healthcare infrastructure, and rising awareness about diabetes management. Countries like China, India, and Japan are at the forefront of this expansion. Latin America and the Middle East & and Africa are gradually adopting these technologies, supported by improving healthcare access and rising health awareness. Overall, the market's growth is shaped by regional healthcare priorities, economic conditions, and the urgency of addressing diabetes-related health challenges.

Self-monitoring Blood Glucose Devices Market- Competitive Landscape:

The Self-Monitoring Blood Glucose (SMBG) Devices Market is characterized by intense competition among established players and emerging innovators. Leading companies such as Abbott Laboratories, Dexcom, Roche Diagnostics, LifeScan, and Ascensia Diabetes Care dominate the market with their advanced technologies and extensive distribution networks. Abbott's FreeStyle Libre series has revolutionized glucose monitoring with its sensor technology and affordability, while Dexcom's G6 and G7 systems are renowned for their accuracy and user-friendly design. Roche's Accu-Chek line continues to be a trusted choice for many, emphasizing reliability and integration with digital health platforms. LifeScan's OneTouch products are designed for simplicity and accuracy, catering to a broad user base. Ascensia's Contour series is known for its reliability and user-friendly design. The market is also witnessing the entry of new players like Ultrahuman, which launched its continuous glucose monitor, Ultrahuman M1, targeting both athletes and health-conscious consumers. Strategic collaborations, technological advancements, and a focus on user-centric designs are key factors driving competition and innovation in the SMBG devices market.

Recent Developments:

In July 2024, Roche received CE Mark for its Accu-Chek SmartGuide(R) continuous glucose monitoring (CGM) device. Designed for adults with type 1 and type 2 diabetes, it offers real-time glucose readings and AI-powered predictive alerts for improved self-management.

In May 2024, Intuity Medical and embecta have announced a commercial collaboration to expand access to Intuity's POGO Automatic(R) Blood Glucose Monitoring System, aiming to enhance self-monitoring options and diabetes care for patients across the United States.

In April 2023, Astellas and Roche Diabetes Care Japan partnered to develop and commercialize an integrated diabetes self-management solution featuring Roche's blood glucose monitoring devices and the BlueStar digital health platform, aiming to improve diabetes care in Japan.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Acon Laboratories, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care
  • B. Braun Melsungen AG
  • Bayer AG
  • Dexcom, Inc.
  • Eli Lilly and Company
  • GlucoMe
  • i-SENS, Inc.
  • LifeScan, Inc.
  • Medtronic plc
  • Nipro Corporation
  • Nova Biomedical
  • PHC Holdings Corporation
  • Roche Diagnostics
  • Sanofi
  • Terumo Corporation
  • Trividia Health, Inc.
  • Ypsomed Holding AG

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Self-Monitoring Blood Glucose (SMBG) Meters
  • Test Strips
  • Lancets
  • Continuous Glucose Monitors

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Electrochemical
  • Photometric

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY TESTING SITE- MARKET ANALYSIS, 2019 - 2032

  • Fingertip
  • Alternate Site Testing

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PATIENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgery Centers
  • Diagnostics Center
  • Home Care
  • Other

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Self-monitoring Blood Glucose Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Self-monitoring Blood Glucose Devices Market Snippet by Product Type
    • 2.1.2. Self-monitoring Blood Glucose Devices Market Snippet by Technology
    • 2.1.3. Self-monitoring Blood Glucose Devices Market Snippet by Testing Site
    • 2.1.4. Self-monitoring Blood Glucose Devices Market Snippet by Patient Type
    • 2.1.5. Self-monitoring Blood Glucose Devices Market Snippet by End User
    • 2.1.6. Self-monitoring Blood Glucose Devices Market Snippet by Country
    • 2.1.7. Self-monitoring Blood Glucose Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Self-monitoring Blood Glucose Devices Key Market Trends

  • 3.1. Self-monitoring Blood Glucose Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Self-monitoring Blood Glucose Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Self-monitoring Blood Glucose Devices Market Opportunities
  • 3.4. Self-monitoring Blood Glucose Devices Market Future Trends

4. Self-monitoring Blood Glucose Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Self-monitoring Blood Glucose Devices Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Self-monitoring Blood Glucose Devices Market Landscape

  • 6.1. Self-monitoring Blood Glucose Devices Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Self-monitoring Blood Glucose Devices Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Self-Monitoring Blood Glucose (SMBG) Meters
    • 7.1.3. Test Strips
    • 7.1.4. Lancets
    • 7.1.5. Continuous Glucose Monitors

8. Self-monitoring Blood Glucose Devices Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. Electrochemical
    • 8.1.3. Photometric

9. Self-monitoring Blood Glucose Devices Market - By Testing Site

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Testing Site, 2024 & 2032 (%)
    • 9.1.2. Fingertip
    • 9.1.3. Alternate Site Testing

10. Self-monitoring Blood Glucose Devices Market - By Patient Type

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Patient Type, 2024 & 2032 (%)
    • 10.1.2. Type 1 Diabetes
    • 10.1.3. Type 2 Diabetes
    • 10.1.4. Gestational Diabetes

11. Self-monitoring Blood Glucose Devices Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 11.1.2. Hospitals
    • 11.1.3. Ambulatory Surgery Centers
    • 11.1.4. Diagnostics Center
    • 11.1.5. Home Care
    • 11.1.6. Other

12. Self-monitoring Blood Glucose Devices Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Self-monitoring Blood Glucose Devices Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Self-monitoring Blood Glucose Devices Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Self-monitoring Blood Glucose Devices Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Self-monitoring Blood Glucose Devices Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Self-monitoring Blood Glucose Devices Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Self-monitoring Blood Glucose Devices Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Abbott Laboratories
    • 13.2.2. Acon Laboratories, Inc.
    • 13.2.3. ARKRAY, Inc.
    • 13.2.4. Ascensia Diabetes Care
    • 13.2.5. B. Braun Melsungen AG
    • 13.2.6. Bayer AG
    • 13.2.7. Dexcom, Inc.
    • 13.2.8. Eli Lilly and Company
    • 13.2.9. GlucoMe
    • 13.2.10. i-SENS, Inc.
    • 13.2.11. LifeScan, Inc.
    • 13.2.12. Medtronic plc
    • 13.2.13. Nipro Corporation
    • 13.2.14. Nova Biomedical
    • 13.2.15. PHC Holdings Corporation
    • 13.2.16. Roche Diagnostics
    • 13.2.17. Sanofi
    • 13.2.18. Terumo Corporation
    • 13.2.19. Trividia Health, Inc.
    • 13.2.20. Ypsomed Holding AG

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us